compared the efficacy and safety of a basal-bolus insulin regimen with that of sliding-scale regular insulin (SSI) in hospitalized general medical patients with type 2 diabetes. The prospective ...

The use of an automated insulin delivery (AID) system reduced A1c and hyperglycemia without increasing hypoglycemia in people ...

Medicus Pharma reports over 50% patient enrollment in Phase 2 study for basal cell carcinoma treatment, aiming for FDA fast-track approval. Medicus Pharma Ltd. announced that over 50% of the 60 ...